P

PeterLabs Holdings Bhd
KLSE:PLABS

Watchlist Manager
PeterLabs Holdings Bhd
KLSE:PLABS
Watchlist
Price: 0.2 MYR
Market Cap: 103.2m MYR
Have any thoughts about
PeterLabs Holdings Bhd?
Write Note

PeterLabs Holdings Bhd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PeterLabs Holdings Bhd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
P
PeterLabs Holdings Bhd
KLSE:PLABS
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Apex Healthcare Bhd
KLSE:AHEALTH
Long-Term Debt
myr5.9m
CAGR 3-Years
3%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Long-Term Debt
myr21.5m
CAGR 3-Years
-9%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Long-Term Debt
myr36.1m
CAGR 3-Years
11%
CAGR 5-Years
-2%
CAGR 10-Years
11%
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Long-Term Debt
myr468.7m
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
N/A
K
Kotra Industries Bhd
KLSE:KOTRA
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

PeterLabs Holdings Bhd
Glance View

Market Cap
103.2m MYR
Industry
Pharmaceuticals

PeterLabs Holdings Bhd.is an investment company, which engages in the manufacture, distribution and trading of animal health and nutrition products. The company is headquartered in Nilai, Negeri Sembilan. The company went IPO on 2011-07-26. The firm is engaged in the manufacturing, distribution and trading of animal health and nutrition products. Its segments include Manufacturing and Trading. The Manufacturing segment is engaged in the manufacturing of animal health and nutrition products. The Trading segment is engaged in the trading and distribution of animal health and nutrition products. Its products include biosecurity and disinfectant, compound feed supplement, feed additives, nutritional premix, pharmaceutical and water-soluble supplement. The firm provides technical information exchange with its customer’s supervisors, technicians and in-house veterinarians, livestock information sharing, post-mortem on diseased animals, blood sampling of diseased animals for testing and individualize latest technologies in the manufacture of feed additives for feed and farming industry.

PLABS Intrinsic Value
0.19 MYR
Overvaluation 5%
Intrinsic Value
Price
P

See Also

Back to Top